Research and Development

FDA Commissioner Scott Gottlieb continues his fightback against the US opioid crisis after requesting an unprecedented recall of Endo Pharmaceuticals’ …

Research emerging from the Institute of Cancer Research has revealed the men most statistically at-risk of developing testicular cancer. The …

Kleo Pharmaceutical has moved to appoint industry veteran Doug Manion to the position of CEO. Kleo are a biotech company …

MSD has been hit by a major surprise after an independent monitoring committee raised a warning after an imbalance in …

With Brexit looming, the future of the EMA headquarters in London has been cast in doubt. Pharmafocus spoke to Marie-Agnes …

As the conference came to a conclusion, audience members were invited to offer their thoughts on what the overall message …

Research emerging from the American Diabetes Association’s meeting in San Diego has revealed that the likelihood of developing type 2 …

Sanofi and Regeneron were able to update its PCSK9 therapy Praluent with the positive data showing it could reduce levels …

To print or download a PDF version of this article, click here.

It’s been a week for successful trial news and for drugs being sped through the approval process. Particularly noteworthy is …

Idorsia, the spin-off R&D company of Actelion, has been hit a blow even before it has left the ground. The …

If you want to understand the importance of data, look at Google and Facebook – neither company is out of …

The human papillomavirus (HPV) vaccine began to be implemented in the UK in 2008. It started by immunising girls between …

Huntington’s disease (HD) is a rare and incurable hereditary condition of the central nervous system. The condition can cause involuntary …

AbbVie posted results on upadacitinib, the latest drug in its pipeline for rheumatoid arthritis (RA) and the results have given …